Immunoclin (Immunoclin) Ending Cash Position : $0.15 Mil (As of Oct. 2014)

View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Ending Cash Position?

Immunoclin's Ending Cash Position for the quarter that ended in Oct. 2014 was $0.15 Mil.

Immunoclin's quarterly Ending Cash Position increased from Apr. 2014 ($0.09 Mil) to Jul. 2014 ($0.10 Mil) and increased from Jul. 2014 ($0.10 Mil) to Oct. 2014 ($0.15 Mil).

Immunoclin's annual Ending Cash Position increased from Feb. 2012 ($0.01 Mil) to Jan. 2013 ($0.17 Mil) but then declined from Jan. 2013 ($0.17 Mil) to Jan. 2014 ($0.05 Mil).

Immunoclin Ending Cash Position Historical Data

The historical data trend for Immunoclin's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Ending Cash Position Chart

Immunoclin Annual Data

Trend

Feb12

Jan13

Jan14

Ending Cash Position

0.01

0.17

0.05

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
Ending Cash Position	Get a 7-Day Free Trial									-	-	0.09	0.10	0.15

Immunoclin Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Immunoclin's Ending Cash Position for the fiscal year that ended in Jan. 2014 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.168	+	-0.116
	=	0.05

Immunoclin's Ending Cash Position for the quarter that ended in Oct. 2014 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.096	+	0.05
	=	0.15

Immunoclin Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Immunoclin's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210

Website

http://www.immunoclin.com

Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines